The role of decentralized approaches in clinical trials
Decentralized approaches to clinical trials have been cited as a key trend in the industry for many years. However, the COVID-19 pandemic resulted in a rapid acceleration of the trend. A recent report by Clinical Trials Arena using data analysis by GlobalData[1] found that a “record number of around 1,300 trials with a decentralised and/or
“No Patients – No Payment” risk-sharing program explained
Cromos Pharma launches video explaining its unique risk-sharing program, “No Patients – No Payment”, which aims to enhance the efficiency of clinical trial patient recruitment. The video explains how the US-based international CRO’s proprietary program benefits Sponsors and how they can take advantage of the offer. Efficient patient recruitment for clinical trials Patient recruitment is the largest challenge
